Headlands Research Continues its Rapid Expansion with the Acquisition of Summit Research Network and the Launch of its Fourth...
May 13 2021 - 9:00AM
Headlands Research (www.headlandsresearch.com), a global
next-generation clinical research site organization, today
announced its acquisition of Summit Research Network in Portland,
Oregon. The acquisition follows Headlands’ recent addition of
Artemis Institute for Clinical Research in February of this year.
Coupled with the new acquisition, Headlands Research also launched
its fourth Horizons site in Scottsdale, AZ, which expands its
global network to 15 clinical trial sites.
Summit Research Network, founded in 1976, is dedicated to
improving medical treatment by conducting high quality scientific
research and patient care. Summit Research Network specializes in
the areas of psychiatry, dementia and other age-related memory
conditions such as Alzheimer’s and Lewy Bodies, and operates a
specialized Memory Health Center (www.memoryhealthcenter.com). In
addition, Summit Research Network’s research encompasses a total of
sixteen therapeutic areas, and the site has a sterling reputation
for delivering world-class research data from its more than five
hundred successfully completed clinical trials.
“Summit’s depth of experience in our industry is unparalleled,”
said Mark Blumling, CEO and Founder of Headlands Research. “We are
very excited to have Summit’s forty-five years of seasoned clinical
trial research expertise joining our mission to meaningfully impact
the clinical trials process and to be an industry leader in patient
recruitment diversity.”
“We are delighted to be joining Headlands Research and their
impressive global network of clinical trial research sites that are
scaling at a rapid pace,” said James Hockley, President of Summit
Research Network. “We share a common vision to make a positive
impact in the clinical trials process, enrich diversity, improve
patient care, and drive scientific knowledge forward in the
industry. After learning more about their mission, leadership and
competencies, it was clear to see the natural fit and how both
organizations can accelerate the collective impact we can have on
the clinical trials process.”
The new Horizons site, based in Scottsdale, complements an
already robust Horizons suite of clinical trial sites, including
Orlando and Sarasota in Florida, as well as Brownsville in Texas.
The clinical research at the Scottsdale location is focused on
several of Headlands’ Center of Excellence research areas,
including Neurology, Psychiatry, NASH, Infectious Disease, Vaccine
and General Medicine.
“By extending our platform footprint to the Southwest, the
Scottsdale Horizons Site is an important geographical expansion of
Headlands, but most importantly, it is representative of Headlands’
continued commitment and focus on patient diversity,” said Mark
Blumling.
About Headlands ResearchHeadlands Research was
founded on the idea that clinical trial research needs to
significantly evolve to better match the current healthcare
climate, as well as the real-world needs of clinical trial
participants. Its mission is to profoundly change the clinical
process through a platform of best-in-class research facilities
that gather high-quality data through increased trial participation
while addressing specialty populations that are underserved. Based
in San Francisco and backed by KKR, Headlands
aims to ensure that high-quality therapeutics are made available to
patients who can benefit from them. Additional information about
the company is available
at www.headlandsresearch.com.
About KKRKKR is a leading global investment
firm that manages multiple alternative asset classes, including
private equity, energy, infrastructure, real estate and credit,
with strategic partners that manage hedge funds. The investment in
Headlands is being funded through KKR’s Health Care Strategic
Growth Fund. KKR aims to generate attractive investment returns for
its fund investors by following a patient and disciplined
investment approach, employing world-class people, and driving
growth and value creation with KKR portfolio companies. KKR invests
its own capital alongside the capital it manages for fund investors
and provides financing solutions and investment opportunities
through its capital markets business. References to KKR’s
investments may include the activities of its sponsored funds. For
additional information about KKR & Co. Inc. (NYSE: KKR), please
visit KKR’s website at www.kkr.com.
Media Contact:Christian SebastianHeadlands Research
media@headlandsresearch.com
KKR (NYSE:KKR)
Historical Stock Chart
From Mar 2024 to Apr 2024
KKR (NYSE:KKR)
Historical Stock Chart
From Apr 2023 to Apr 2024